Nothing Special   »   [go: up one dir, main page]

BR112014032956A2 - processos para preparação de 1,2,4-oxadiazois 3,5-dissubstituídos - Google Patents

processos para preparação de 1,2,4-oxadiazois 3,5-dissubstituídos

Info

Publication number
BR112014032956A2
BR112014032956A2 BR112014032956A BR112014032956A BR112014032956A2 BR 112014032956 A2 BR112014032956 A2 BR 112014032956A2 BR 112014032956 A BR112014032956 A BR 112014032956A BR 112014032956 A BR112014032956 A BR 112014032956A BR 112014032956 A2 BR112014032956 A2 BR 112014032956A2
Authority
BR
Brazil
Prior art keywords
disubstituted
processes
oxadiazols
preparing
reaction
Prior art date
Application number
BR112014032956A
Other languages
English (en)
Other versions
BR112014032956B1 (pt
Inventor
Richard Graham Charles
Louis Brown David
Harold Miller William
Original Assignee
Monsanto Technology Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Technology Llc filed Critical Monsanto Technology Llc
Publication of BR112014032956A2 publication Critical patent/BR112014032956A2/pt
Publication of BR112014032956B1 publication Critical patent/BR112014032956B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

resumo patente de invenção: "processos para preparação de 1,2,4-oxadiazois 3,5-dissubstituídos". a presente invenção refere-se a processos para a preparação de 1,2,4-oxadiazois 3,5-dissubstituídos e seus sais compreendendo uma reação de n-hidroxiamidina com um cloreto de acila em uma mistura de reação compreendendo um solvente orgânico imiscível em água e uma base aquosa em temperaturas de reação relativamente baixas.
BR112014032956-7A 2012-07-02 2013-07-02 Processos para preparação de 1,2,4-oxadiazois 3,5-dissubstituídos BR112014032956B1 (pt)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201261667361P 2012-07-02 2012-07-02
US61/667,361 2012-07-02
US201361777210P 2013-03-12 2013-03-12
US61/777,210 2013-03-12
US201361783466P 2013-03-14 2013-03-14
US61/783,466 2013-03-14
PCT/US2013/049060 WO2014008257A2 (en) 2012-07-02 2013-07-02 Processes for the preparation of 3,5-disubstituted-1,2,4-oxadiazoles

Publications (2)

Publication Number Publication Date
BR112014032956A2 true BR112014032956A2 (pt) 2017-06-27
BR112014032956B1 BR112014032956B1 (pt) 2020-02-27

Family

ID=49882590

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014032956-7A BR112014032956B1 (pt) 2012-07-02 2013-07-02 Processos para preparação de 1,2,4-oxadiazois 3,5-dissubstituídos

Country Status (13)

Country Link
US (2) US9040711B2 (pt)
EP (1) EP2867230B1 (pt)
CN (1) CN104428296B (pt)
AR (1) AR091655A1 (pt)
AU (1) AU2013286860B2 (pt)
BR (1) BR112014032956B1 (pt)
CA (1) CA2876215A1 (pt)
DK (1) DK2867230T3 (pt)
ES (1) ES2782509T3 (pt)
MX (1) MX352351B (pt)
UA (1) UA114915C2 (pt)
WO (1) WO2014008257A2 (pt)
ZA (1) ZA201409000B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101664818B1 (ko) 2007-08-13 2016-10-11 몬산토 테크놀로지 엘엘씨 선충류 방제용 조성물 및 방법
UA118254C2 (uk) 2012-12-04 2018-12-26 Монсанто Текнолоджи Ллс Нематоцидні водні композиції концентрату суспензії
BR112015021452A2 (pt) 2013-03-15 2017-07-18 Monsanto Technology Llc azóis n-,c-dissubstituídos para controlar pragas de nematódeos
UY35435A (es) 2013-03-15 2014-10-31 Monsanto Technology Llc ?1,3,4-oxadiazol-2(3h)-onas 3,5-disustituidas y composiciones y métodos para controlar plagas de ne matodos?.
CN103980265A (zh) * 2014-05-14 2014-08-13 武汉工程大学 3-苯基-5-(噻吩-2基)-1,2,4-噁二唑的合成工艺
US10982293B2 (en) 2014-05-20 2021-04-20 Monsanto Technology Llc Methods for improving plant resistance to soybean cyst nematode and compositions thereof
US20170367338A1 (en) * 2014-12-19 2017-12-28 Monsanto Technology Llc Compositions and methods for improving agronomic characteristics of plants
JP6536670B2 (ja) 2015-03-06 2019-07-03 Ａｇｃ株式会社 １，２，４−オキサジアゾール誘導体の製造方法
WO2016143654A1 (ja) * 2015-03-06 2016-09-15 旭硝子株式会社 １，２，４－オキサジアゾール誘導体の製造方法
WO2016150937A1 (en) 2015-03-25 2016-09-29 Lonza Ltd Method for preparation of thiophenecarbonyl chlorides
KR102096420B1 (ko) * 2015-03-31 2020-04-02 몬산토 테크놀로지 엘엘씨 2-싸이오펜카보닐 클로라이드의 제조 방법
WO2017076844A1 (en) * 2015-11-04 2017-05-11 Lonza Ltd Method for preparation of thiophene-2-carbonyl chlorides with oxalyl chloride
EP3433242A4 (en) * 2016-03-24 2020-02-26 Monsanto Technology LLC METHOD FOR PRODUCING HETEROARYL CARBONIC ACIDS
CN111675672A (zh) * 2020-05-12 2020-09-18 石家庄市度智医药科技有限公司 一种制备阿塔鲁伦的方法

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL120029C (pt) 1959-09-29
US3218331A (en) 1962-04-17 1965-11-16 Union Carbide Corp Preparation of substituted oxadiazoles
NL291628A (pt) 1962-04-17
US3227725A (en) 1962-04-17 1966-01-04 Union Carbide Corp Certain 3,5-disubstituted 1,2,4-oxadiazole compounds
US3211742A (en) 1962-04-17 1965-10-12 Union Carbide Corp Process for preparing oxadiazoles
US3264318A (en) 1964-04-29 1966-08-02 Union Carbide Corp Process for the production of substituted oxadiazoles
JPS62241946A (ja) 1986-04-14 1987-10-22 Tonen Sekiyukagaku Kk 熱可塑性樹脂組成物
JPH03258779A (ja) 1990-03-06 1991-11-19 Mitsui Toatsu Chem Inc イミダゾール誘導体及び該イミダゾール誘導体を有効成分とする抗痙攣剤
DE19725450A1 (de) 1997-06-16 1998-12-17 Hoechst Schering Agrevo Gmbh 4-Haloalkyl-3-heterocyclylpyridine und 4-Haloalkyl-5-heterocyclylpyrimidine, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel
US6660753B2 (en) 1999-08-19 2003-12-09 Nps Pharmaceuticals, Inc. Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
US7041685B2 (en) 2001-06-08 2006-05-09 Cytovia, Inc. Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
CA2509224A1 (en) 2002-12-18 2004-07-15 Cytovia, Inc. 3,5-disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
EP1618098B1 (en) * 2003-04-11 2014-11-19 PTC Therapeutics, Inc. 1,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease
US20050075375A1 (en) 2003-05-14 2005-04-07 Anadys Pharmaceuticals, Inc. Heterocyclic compounds for treating hepatitis C virus
JP2008509139A (ja) * 2004-08-03 2008-03-27 メルク エンド カムパニー インコーポレーテッド １，３−二置換ヘテロアリールｎｍｄａ／ｎｒ２ｂ拮抗薬
WO2006115188A1 (ja) 2005-04-22 2006-11-02 Daiichi Sankyo Company, Limited ヘテロ環化合物
GB0601744D0 (en) 2006-01-27 2006-03-08 Novartis Ag Organic compounds
TWI408139B (zh) 2006-09-07 2013-09-11 Actelion Pharmaceuticals Ltd 新穎噻吩衍生物
WO2008030570A1 (en) 2006-09-08 2008-03-13 Ptc Therapeutics, Inc. Processes for the preparation of 1,2,4-oxadiazole benzoic acids
JP2008120794A (ja) 2006-10-16 2008-05-29 Daiichi Sankyo Co Ltd ヘテロ環化合物を含有する医薬組成物
US8486979B2 (en) 2006-12-12 2013-07-16 Abbvie Inc. 1,2,4 oxadiazole compounds and methods of use thereof
KR101664818B1 (ko) 2007-08-13 2016-10-11 몬산토 테크놀로지 엘엘씨 선충류 방제용 조성물 및 방법
WO2009041972A1 (en) 2007-09-27 2009-04-02 University Of Notre Dame Du Lac Antibacterial compounds and methods of using same
GB0725102D0 (en) 2007-12-21 2008-01-30 Glaxo Group Ltd Compounds
EP2297140A4 (en) 2008-06-06 2012-05-02 Abbott Lab NOVEL 1,2,4-OXADIAZOLE COMPOUNDS AND METHODS OF USE
WO2010054763A1 (de) 2008-11-14 2010-05-20 Bayer Schering Pharma Aktiengesellschaft Heterocyclisch substituierte aryl-verbindungen als hif-inhibitoren
EP2202232A1 (en) 2008-12-26 2010-06-30 Laboratorios Almirall, S.A. 1,2,4-oxadiazole derivatives and their therapeutic use
EP2396321B1 (en) 2009-02-10 2015-05-06 Monsanto Technology LLC Compositions and methods for controlling nematodes
EP2241558A1 (en) 2009-04-03 2010-10-20 Merck Serono SA Oxadiazole derivatives
US9040568B2 (en) 2009-05-29 2015-05-26 Abbvie Inc. Pharmaceutical compositions for the treatment of pain
AR076984A1 (es) 2009-06-08 2011-07-20 Merck Serono Sa Derivados de pirazol oxadiazol
CA2786716A1 (en) 2010-01-11 2011-07-14 Mithridion, Inc. Compounds and compositions for cognition-enhancement, methods of making, and methods of treating
JP5727002B2 (ja) 2010-05-08 2015-06-03 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ 置換ヘテロサイクリルベンジルピラゾール類およびその使用
EP2585458B1 (en) 2010-06-22 2015-01-07 Chiesi Farmaceutici S.p.A. Alkaloid aminoester derivatives and medicinal compositions thereof
WO2012012477A1 (en) 2010-07-20 2012-01-26 Bristol-Myers Squibb Company Substituted 3-phenyl-1,2,4-oxadiazole compounds
CN103221397B (zh) 2010-09-02 2016-04-13 孟山都技术公司 用于防治线虫害虫的新组合物及方法

Also Published As

Publication number Publication date
MX352351B (es) 2017-11-21
AU2013286860B2 (en) 2017-10-26
UA114915C2 (uk) 2017-08-28
ES2782509T3 (es) 2020-09-15
MX2014015794A (es) 2015-03-10
US20150225382A1 (en) 2015-08-13
DK2867230T3 (da) 2020-04-14
ZA201409000B (en) 2017-04-26
CN104428296B (zh) 2017-11-14
US20140039197A1 (en) 2014-02-06
US9273037B2 (en) 2016-03-01
EP2867230B1 (en) 2020-02-12
US9040711B2 (en) 2015-05-26
AR091655A1 (es) 2015-02-18
WO2014008257A3 (en) 2014-02-27
AU2013286860A1 (en) 2015-01-22
CA2876215A1 (en) 2014-01-09
EP2867230A4 (en) 2016-04-13
EP2867230A2 (en) 2015-05-06
BR112014032956B1 (pt) 2020-02-27
CN104428296A (zh) 2015-03-18
WO2014008257A2 (en) 2014-01-09

Similar Documents

Publication Publication Date Title
BR112014032956A2 (pt) processos para preparação de 1,2,4-oxadiazois 3,5-dissubstituídos
CR20150629A (es) Compuestos químicos
BR112015028853A2 (pt) Composição detergente com ph baixo
DOP2013000239A (es) Derivados de ácido 3-fenilpropiónico ramificados y su uso.
DOP2015000170A (es) Compuestos químicos
CL2012003681A1 (es) Compuestos derivados de piperidina; composicion farmaceutica; y su uso como inhibidores de acetil-coa carboxilasa para el tratamiento de trastornos metabolicos, tales como obesidad y diabetes.
CR20140435A (es) Nuevos derivados de tienopirimidina, procesos para su preparacion y sus usos terapeuticos
CU20160004A7 (es) Bencil-1 h-pirazolo[3,4-b]piridinas
BR112013022556A2 (pt) composição farmacêutica aquosa semissólida contendo tapentadol
BR112014012918A2 (pt) processo para preparar um sal de ácido, ácido, sal de sódio ácido, e, uso de um ácido
BR112015002809A2 (pt) solução aceleradora adequada para formar um sistema redox com peróxidos, e composição de dois componentes
BR112014027808A2 (pt) sal polimórfico do sal de oxalato de 6-o-(4-dimetilaminoetoxi) cinaroil fumagilol e métodos de produção e utilização do mesmo
BR112015007492A2 (pt) pré-mistura estabilizadora de enzima estável
BR112013028531A2 (pt) composição inseticida líquida
PH12016500913A1 (en) Soap bar
BR112015006692A2 (pt) formulação de nanodispersão, método para administrar uma formulação de nanodispersão líquida de taxina livre de etanol em um indivíduo, e, kit.
BR112014009760A2 (pt) análogos de ácido siálico, seu uso e composição farmacêutica e composição farmacêutica de liberação sustentada os compreendendo
BR112015006844A2 (pt) um elemento de contato com a pele que compreende ao menos uma substância sensibilizante termicamente resiliente
BR112015029073A2 (pt) tinturas dispersas, sua preparação e seu uso
BR112015006243A2 (pt) agentes antibacterianos de fenicol
TR201911194T4 (tr) Solunabilir bir ilaç.
BR112015030589A8 (pt) formas polimórficas de fosfato de icotinibe, composição farmacêutica compreendendo as referidas formas e usos das mesmas
BR112015020611A2 (pt) compostos de carboxamida
BR112016016469A8 (pt) composição farmacêutica líquida, composição parenteral, processo para produção das referidas composições farmacêuticas e kit de partes.
AR093901A1 (es) Proceso mejorado para la preparacion de determinadas sulfiliminas sustituidas

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 02/07/2013, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 9A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2677 DE 26-04-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.